CSF3 and early-onset autosomal dominant Alzheimer disease: Numerous reports have described the efficacy of G-CSF in animal models of different neurological diseases including stroke [9], [34]–[37], Parkinson's disease [38], [39], and recently Alzheimer's disease [40] and amyotrophic lateral sclerosis [41].